Aratana Therapeutics - InvestorRoom http://aratana.investorroom.com/ Aratana Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results http://aratana.investorroom.com/2017-03-13-Aratana-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2016-Financial-Results Mon, 13 Mar 2017 16:26:00 -0400 http://aratana.investorroom.com/2017-03-13-Aratana-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2016-Financial-Results Aratana Therapeutics to Present at Barclays Capital Global Healthcare Conference http://aratana.investorroom.com/2017-03-08-Aratana-Therapeutics-to-Present-at-Barclays-Capital-Global-Healthcare-Conference Wed, 08 Mar 2017 16:05:00 -0500 http://aratana.investorroom.com/2017-03-08-Aratana-Therapeutics-to-Present-at-Barclays-Capital-Global-Healthcare-Conference Aratana Therapeutics to Report Fourth Quarter and Full Year 2016 Financial Results http://aratana.investorroom.com/2017-02-22-Aratana-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2016-Financial-Results Wed, 22 Feb 2017 16:05:00 -0500 http://aratana.investorroom.com/2017-02-22-Aratana-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2016-Financial-Results Aratana Therapeutics to Attend North American Veterinary Conference http://aratana.investorroom.com/2017-02-03-Aratana-Therapeutics-to-Attend-North-American-Veterinary-Conference Provides Update on Availability of ENTYCE® (capromorelin oral solution) Fri, 03 Feb 2017 17:10:00 -0500 http://aratana.investorroom.com/2017-02-03-Aratana-Therapeutics-to-Attend-North-American-Veterinary-Conference Galliprant® (grapiprant tablets) Now Available for Canine Osteoarthritis http://aratana.investorroom.com/2017-01-24-Galliprant-R-grapiprant-tablets-Now-Available-for-Canine-Osteoarthritis Elanco launches first-in-class piprant for veterinary use Tue, 24 Jan 2017 16:35:00 -0500 http://aratana.investorroom.com/2017-01-24-Galliprant-R-grapiprant-tablets-Now-Available-for-Canine-Osteoarthritis